Contract Research

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002534: The value of fast diagnostics in time-critical infections

Shaheer Hassan, Thomas Hamlyn, Henry Fong and Grace Hampson

002531: The burden of LDL-cholesterol-driven atherosclerotic cardiovascular diseases

George Bray, Brittany Darrow and Chris Skedgel

002529: Evaluating novel antimicrobials within EU joint clinical assessments

Angus Macfarlane, George Bray, Matthias Hofer and Grace Hampson

002527: Novel devices: optimising drug delivery in multiple myeloma

Henry Fong, Patricia Cubi-Molla and Martina Garau

002524: A global landscape analysis of access to tumour-agnostic therapies

Henry Fong, Priscila Radu, Nadine Henderson, Martina Garau and Lotte Steuten

002523: Achieving Accelerated Patient Access to Cancer Care in Europe

George Bray, Martina Garau, Patricia Cubi-Molla, Lotte Steuten and Adrian Towse

002517: The broader economic benefits of COVID-19 vaccination

Hania El Banhawi, Sian Hodgson, Margherita Neri and Lotte Steuten

002513: The value of cell and gene therapies to the UK economy

Chris Sampson, Sukanya Subramaniyan, Matthew Napier, Hania El Banhawi, Panos Kefalas, Laura Beswick, Jacqueline Barry, Matthew Durdy and Grace Hampson

002507: Altering the trajectory of HIV in Europe

Priscila Radu, Helen Hayes, Ellie Tunnicliffe, David Mott and Grace Hampson

002506: Taking STRIDES: The value of diagnostics against AMR

Henry Fong, George Bray, Grace Hampson and Lotte Steuten

002505: Altering the Trajectory of HIV in Europe

Priscila Radu;Helen Hayes;Ellie Tunnicliffe;David Mott;Grace Hampson

002504: Understanding the Full Value of Long-Acting Therapies: less is more?

Hania El Banhawi;Henry Fong;Matthias Hofer;Lotte Steuten

002503: An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Brittany Darrow;Sulayman Chowdhury;Phill O’Neill;Nadine Henderson

002502: Analysing Global Immunisation Expenditure

Ellie Tunnicliffe;Helen Hayes;Phill O’Neill;SooChin Yen;Simon Brassel;Lotte Steuten

002501: The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Claud Theakston;Matthias Hofer;Martina Garau;Lotte Steuten

002500: Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Nadine Henderson;Paul Oyalo;Ellie Tunnicliffe;Hania El Banhawi;SooChin Yen;Grace Hampson

002498: The Importance of Diversity of Supply in Rare Diseases Markets

Matthew Napier;Brittany Darrow;Matthias Hofer;Mikel Berdud;Amanda Cole

002496: Employer Costs from Respiratory Infections

Helen Hayes;Brittany Darrow;Lotte Steuten;Graham Cookson;Amanda Cole

002495: Understanding societal preferences for priority by disease severity in England & Wales

Helen Hayes;Priscila Radu;David Mott;Chris Skedgel

002493: The Cost of Drug Shortages

Matthew Napier;Mikel Berdud;Amanda Cole

002492: Unlocking the Value of Combination Therapies

George Bray;Lotte Steuten;Gayathri Kumar

002491: Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding

Sian Hodgson;Helen Hayes;Patricia Cubi-Molla;Martina Garau

002490: A Framework for Value-aligned Pricing of Combination Therapies

Christopher Sampson

002489: How Have HTA Agencies Evolved Their Methods Over Time?

Priscila Radu;Gayathri Kumar;Patricia Cubi-Molla;Martina Garau;Eleanor Bell;Jia Pan;Ramiro Gilardino ;Julie Van Bavel;Agnes Brandtmüller;Katherine Nelson;Melinda Goodall

002488: Socio-Economic Value of Adult Immunisation Programmes

Hania El Banhawi;Sulayman Chowdhury;Margherita Neri;Priscila Radu;Sian Hodgson;Eleanor Bell;Simon Brassel;Lotte Steuten

002487: Incorporating the Patient Voice in Health Technology Assessment

Gayathri Kumar;George Bray;Jia Pan;Chris Skedgel;Kyle Dunton;Francisco Fonseca Santos;Paul Genin;Gunnar Schroefel

002486: Developing a Conceptual Framework of Healthcare System Pressure

Simon Brassel;Margherita Neri;Lotte Steuten;Hannah Schirrmacher;Fernando Albuquerque de Almeida;Apostolos Charos;Katharina Schley;Kimberly Shea

002485: The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?

Gayathri Kumar;Matthew Napier;Margherita Neri;Martina Garau

002483: The Dynamics of Drug Shortages

Matthew Napier;Dimitrios Kourouklis;Amanda Cole;Graham Cookson

002480: Capturing the Broader Value of Antibiotics

Simon Brassel;Isobel Firth;Sulayman Chowdhury;Grace Hampson;Lotte Steuten

002479: Innovation for Health System Efficiency and Improvement

Margherita Neri;Matthias Hofer;Fred McElwee;Jia Pan;Graham Cookson

002478: Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

Matthias Hofer;Grace Hampson

002477: Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Matthias Hofer;Grace Hampson

002474: Supporting the Era of Green Pharmaceuticals in the UK

Jake Hitch;Nadine Henderson;Graham Cookson;Isobel Firth

002473: Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Adrian Towse;Lotte Steuten

002471: Navigating the Landscape of Digital Health - United Kingdom

Simon Brassel;Priscila Radu;Eleanor Bell;Martina Garau

002470: Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Sian Hodgson;Amanda Cole;Raoh-Fang Pwu;Jason Chia-Hsun Hsieh

002469: A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Isobel Firth;Jia Pan;Adrian Towse;Lotte Steuten

002468: The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

Christopher Sampson

002467: Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

Sian Hodgson;Dimitrios Kourouklis;Phill O’Neill;Martina Garau

002466: The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

Nadine Henderson;Chris Skedgel;Claud Theakston

002464: NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Nadine Henderson;Simon Brassel;Phill O’Neill;Rachel Allen;Jonathan Cooke;Martina Garau

002463: Are Recommendations for HTA of Gene Therapies Being Achieved?

Sian Hodgson;Nadine Henderson;Matthew Napier;Amanda Cole;Grace Hampson

002462: Delivering the Triple Win: A Value-Based Approach to Pricing

Eleanor Bell;Mikel Berdud;Graham Cookson;Sian Hodgson

002461: Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Simon Brassel;Isobel Firth;Edward Oliver;Grace Hampson;Adrian Towse;Lotte Steuten

002448: Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Sian Hodgson;Nadine Henderson;Adrian Towse;Amanda Cole

002394: Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Graham Cookson;Jake Hitch

002386: The Value of Vaccines in Maintaining Health System Capacity in England

Simon Brassel;Margherita Neri;Lotte Steuten

002377: A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Maria Errea;Nadine Henderson;Chris Skedgel;Mireia Jofre-Bonet

002370: The Lower Drug Costs Now Act and Pharmaceutical Innovation

Lou Garrison;Jake Hitch;Grace Hampson;Mireia Jofre-Bonet;Martina Garau;Graham Cookson